Markus Wallner

E-Mailmar.wallnersalkat

Müllner Hauptstrasse 48
5020 Salzburg
Österreich

Publikationen pro Jahr

Fingerprint

Ergründen Sie die Forschungsthemen, in denen Markus Wallner aktiv ist. Diese Themenbezeichnungen stammen aus den Werken dieser Person. Zusammen bilden sie einen einzigartigen Fingerprint.

1 Ähnliche Profile

2 Originalarbeit

Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trial
Schwegel, N., Strohhofer, C., Kolesnik, E., Oltean, S., Huettmair, A., Pipp, C., Benedikt, M., Verheyen, N., Gollmer, J., Ablasser, K., Wallner, M. (Co-Autor/-in), Santner, V., Tripolt, N., Pferschy, P., Zechner, P., Alber, H., Siller-Matula, J. M., Kopp, K. (Co-Autor/-in), Zirlik, A. & Aziz, F. &2 mehr, Sourij, H. & von Lewinski, D., 16 Sept. 2024, in: CLINICAL RESEARCH IN CARDIOLOGY : OFFICIAL JOURNAL OF THE GERMAN CARDIAC SOCIETY. 11 S.
Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

Open Access
Lack of microbiological awareness on the ward as a key factor for inappropriate use of anti-infectives: results of a point prevalence study and user satisfaction survey in a large university hospital in Austria
Kern, J. M. (Erstautor/-in), Berger, K., Lechner, A. (Co-Autor/-in), Porsche, U., Wallner, M. (Co-Autor/-in) & Past, E. M. (Letztautor/-in), 2023, in: INFECTION .
Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

Open Access

Markus Wallner

Fingerprint

Publikationen

Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trial

Lack of microbiological awareness on the ward as a key factor for inappropriate use of anti-infectives: results of a point prevalence study and user satisfaction survey in a large university hospital in Austria